Signal library
A library of all the signals published in the WHO Pharmaceuticals Newsletter since 2012.
More information could emerge after publication which might alter the conclusion in the assessments. For more information on signals, please see "General information on signals in the WHO Pharmaceuticals Newsletter", "What is a signal?" and Signal detection at UMC.
For more information on issues relating to the tentative nature of data underlying signals and to data protection matters please read the UMC caveat document.
For details on the UMC measures of disproportionate reporting please read Disproportionate Reporting.
136 documents found.
-
SignalsDronedarone – polyneuropathy
WHO Pharmaceuticals Newsletter, 2014, No.4, p19.
Author: UMC
Date: 2014-09-29 -
Signals
Agomelatine - hypotension
WHO Pharmaceuticals Newsletter, 2014, No.4, p13.
Date: 2014-09-29 -
Signals
Finasteride - convulsions
WHO Pharmaceuticals Newsletter, 2014, No.4, p23.
Author: UMC
Date: 2014-09-29 -
Signals
Dronedarone - AV Block
WHO Pharmaceuticals Newsletter, 2014, No.3, p10.
Author: Raquel Herrera Comoglio
Date: 2014-06-23 -
Signals
Ustekinumab - Vasculitis
WHO Pharmaceuticals Newsletter, 2014, No.3, p18.
Date: 2014-06-23 -
Signals
Vemurafenib - renal failure
WHO Pharmaceuticals Newsletter, 2014, No.3, p23.
Author: Ian Boyd
Date: 2014-06-23 -
Signals
Citalopram and ramipiril – hyponatraemia
WHO Pharmaceuticals Newsletter, 2014, No.2, p10.
Author: Staffan Hägg
Date: 2014-05-30 -
Signals
Vemurafenib – pancreatitis
WHO Pharmaceuticals Newsletter, 2014, No.2, p23.
Author: Daniele Sartori
Date: 2014-05-30 -
Signals
Tocilizumab – Psoriasis and aggravated psoriasis
WHO Pharmaceuticals Newsletter, 2014, No.2, p16.
Author: Ruth Savage
Date: 2014-05-30 -
Signals
Combined Ibuprofen and Metamizole treatment - Acute renal failure
WHO Pharmaceuticals Newsletter, 2014, No.2, p13.
Author: Staffan Hägg
Date: 2014-05-30 -
Signals
Roflumilast - pancreatitis
WHO Pharmaceuticals Newsletter, 2014, No.1, p26.
Date: 2014-03-21 -
Signals
Ibuprofen - erectile dysfunction
WHO Pharmaceuticals Newsletter, 2014, No.1, p18.
Author: Alfonso Carvajal
Date: 2014-03-21 -
Signals
Vemurafenib - granulocytopenia
WHO Pharmaceuticals Newsletter, 2014, No.1, p30.
Author: Geraldine Hill, Ronald Meyboom
Date: 2014-03-21 -
Signals
Emtricitabine/Efavirenz/Tenofovir Disoproxil Fumarate - Phosphatase Alkaline Increased
WHO Pharmaceuticals Newsletter, 2014, No.1, p14.
Author: Alfonso Carvajal
Date: 2014-03-21 -
Signals
Parathyroid hormone – myocardial ischaemia
WHO Pharmaceuticals Newsletter, 2014, No.1, p21.
Author: Ian Boyd
Date: 2014-03-21 -
Signals
Golimumab - Meningitis
WHO Pharmaceuticals Newsletter, 2013, No.4, p27.
Author: Ariel E. Arias
Date: 2014-01-24 -
Signals
Pazopanib - Pericardial Effusion
WHO Pharmaceuticals Newsletter, 2013, No.4, p30.
Author: Ian Boyd
Date: 2014-01-24 -
Signals
Abiraterone - Thrombocytopenia
WHO Pharmaceuticals Newsletter, 2013, No.6, p18.
Author: Raquel Herrera Comoglio
Date: 2014-01-24 -
Signals
Baclofen - Renal failure
WHO Pharmaceuticals Newsletter, 2013, No.4, p26.
Author: Michael Langman
Date: 2014-01-24 -
Signals
Roflumilast - Melaena
WHO Pharmaceuticals Newsletter, 2013, No.4, p18.
Author: Tamás Paál
Date: 2013-10-29 -
Signals
Tapentadol - Delusion
WHO Pharmaceuticals Newsletter, 2013, No.4, p23.
Author: Ian Boyd
Date: 2013-10-29 -
Signals
Mirtazapine - Rhabdomyolysis
WHO Pharmaceuticals Newsletter, 2013, No.5, p15.
Date: 2013-10-29 -
Signals
Tapentadol - Aggressive reaction
WHO Pharmaceuticals Newsletter, 2013, No.4, p19.
Author: Ian Boyd
Date: 2013-08-30 -
Signals
Agomelatine - QT prolonged
WHO Pharmaceuticals Newsletter, 2013, No.4, p12.
Author: Raquel Herrera Comoglio
Date: 2013-08-30 -
Signals
Fluoxetine - Deafness
WHO Pharmaceuticals Newsletter, 2013, No.3, p14.
Author: Emilio J. Sanz, Carlos de Las Cuevas
Date: 2013-07-11 -
Signals
Propylthiouracil - Stevens-Johnson syndrome, Erythema multiforme and Epidermal necrolysis
WHO Pharmaceuticals Newsletter, 2013, No.2, p13.
Author: Zarif Jabbar-Lopez
Date: 2013-04-01 -
Signals
Febuxostat - Hepatic failure
WHO Pharmaceuticals Newsletter, 2013, No.2, p11.
Author: Richard Hill
Date: 2013-04-01 -
Signals
Fesoterodine - GI haemorrhage
WHO Pharmaceuticals Newsletter, 2012, No.6, p11.
Author: Richard Hill
Date: 2012-12-01 -
Signals
Saxagliptin - Pancreatitis
WHO Pharmaceuticals Newsletter, 2012, No.1, p16.
Date: 2012-11-01 -
Signals
Venlafaxine - Eclampsia, preeclampsia and related disorders of pregnancy
WHO Pharmaceuticals Newsletter, 2012, No.1, p19.
Date: 2012-11-01 -
Signals
Mometasone – Arrhythmia
WHO Pharmaceuticals Newsletter, 2012, No.4, p20.
Author: Ian Boyd
Date: 2012-08-01 -
Signals
Dronedarone - Hyperparathyroidism and decreased Thyroid Stimulating Hormone
WHO Pharmaceuticals Newsletter, 2012, No.4, p14.
Date: 2012-08-01 -
Signals
Everolimus - Serious gastroinstestinal disorders
WHO Pharmaceuticals Newsletter, 2012, No.3, p13.
Date: 2012-06-01 -
Signals
Ondansetron - Serotonin syndrome
WHO Pharmaceuticals Newsletter, 2012, No.3, p16.
Date: 2012-06-01 -
Signals
Donepezil – SSRI and SNRI – interaction and Serotonin syndrome
WHO Pharmaceuticals Newsletter, 2012, No.2, p15.
Date: 2012-04-01 -
Signals
Ranolazine - Hallucination
WHO Pharmaceuticals Newsletter, 2012, No.2, p21.
Date: 2012-04-01